ANKRD49 and central nervous system cancer: Through reanalyzing RNA sequencing data of glioma-related datasets in TCGA database, we found that the expression of ANKRD49 was predominantly higher in glioma samples compared with matched normal samples (Figure 1A) (fold change =2.11, P=2.99E-09).